Komori
Lihit Lab. (7975) · RiskSoftened

Risk of disruptions to production, logistics, and sales caused by COVID-19 and large-scale disasters

First written in FY2020. 3 of 8 entries say "Restated". Latest entry: FY2024-Q1.

8entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021-Q2 – FY2021-Q3WorsenedFY2021RestatedFY20222020: 320202021: 220212022: 120222023: 22023
Same theme, other companies
Impact of COVID-19 on business operations, demand, human mobility, and supply chainsA theme 71 companies write about · 71 as a headwind · 0 as a tailwind

Lihit Lab. moved to the "Worse" side of this theme in 2023, 3 years after the typical company in this theme (2020).

The whole theme swung hardest in 2025: 5 of 16 companies on the "Worse" side.

9 other companies' latest entry also says "Softened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 71 companies compared. The sentences above are computed from all 71.
Full recordFilings, disclosures and news, newest first
  1. FY2024-Q1SoftenedAnnual report

    「Reflecting the easing of restrictions aimed at containing COVID-19, domestic demand, including personal consumption centered on spending on services and corporate capital investment, has driven a gradual recovery.」

    The disclosure now refers to the easing of restrictions aimed at containing COVID-19 and the recovery in domestic demand, reducing the previous focus on the continuing impact on sales, production and logistics.
  2. FY2023SoftenedAnnual report

    「The spread of COVID-19 has been brought under control to some extent, including through its reclassification as a Class 5 disease under the Infectious Diseases Control Law. However, if the spread of infections intensifies again, events may be postponed or cancelled in Japan and overseas, and the development schedules, primarily for new products, and production schedules at partner factories may be affected.」

    The disclosure now states that the spread of infections is moving toward containment, reducing the risk from the previously disclosed risk of continued and prolonged impact to a conditional risk involving the impact on event, development and production schedules if infections intensify again.
  3. FY2022RestatedAnnual report

    「Restrictions on economic activity, including business operations and personal consumption, have continued due to the global spread of COVID-19, affecting our operations, including the sales, production and logistics of our products. As the outlook for containing the infections remains uncertain, prolonged restrictions could delay or hamper the economic recovery.」

    We continue to disclose the ongoing impact of the infections on sales, production and logistics, as well as the possibility that the situation may continue for an extended period due to the uncertain outlook for containment.
  4. FY2021WorsenedAnnual report

    「Restrictions on economic activity, including business operations and personal consumption, have continued due to the global spread of COVID-19, affecting our operations, including the sales, production and logistics of our products. As the outlook for containing the infections remains uncertain, prolonged restrictions could delay or hamper the economic recovery.」

    The impact of the infections on sales, production and logistics is explicitly identified as a business risk, and the possibility that the situation may continue for an extended period due to the uncertain outlook for containment is described.
  5. FY2021-Q3RestatedAnnual report

    「The impact of the spread of COVID-19 during the cumulative third quarter of the fiscal year is described in “2. Analysis of Financial Position, Operating Results and Cash Flows by Management, (1) Financial Position and Operating Results,” but depending on how the situation develops, it may affect the financial position, operating results and other aspects of our group.」

    We continue to disclose that the ongoing impact of COVID-19 may affect our financial position, operating results and other aspects depending on how the situation develops.
  6. FY2021-Q2RestatedAnnual report

    「The impact of the spread of COVID-19 is as described in “2. Analysis of Financial Position, Operating Results and Cash Flows by Management, (1) Financial Position and Operating Results,” but depending on developments going forward, it may affect the group’s financial position, operating results and other matters.」

    The company continues to disclose that the ongoing impact of COVID-19 may affect its financial position, operating results and other matters depending on developments going forward.
  7. FY2021-Q1MaterialisedAnnual report

    「However, although the aggressive launch of new products in the Office Supplies and Other Business contributed to sales, it could not fully offset the decline in existing products caused by the impact of COVID-19, resulting in lower sales than in the same period of the previous year.」

    The impact of the spread of COVID-19 has materialized in the form of lower sales of existing products and lower year-on-year sales in the Office Supplies and Other Business.
  8. FY2020First statedAnnual report

    「The global spread of COVID-19 has led to restrictions on movement in various parts of the world, significantly affecting economic activity. If such a pandemic occurs, production activities and logistics functions at the company’s group and domestic and overseas partner companies may be restricted, potentially causing product supply disruptions. Corporate business activity and personal consumption may also contract, potentially affecting product sales.」

    The company identifies production and logistics restrictions, supply disruptions, and contractions in corporate activity and personal consumption caused by a global pandemic as new risks. The spread of COVID-19 and the movement restrictions themselves are described as events that have already occurred.
Moved together

"Higher Procurement Costs and Foreign Exchange Losses Due to Exchange-Rate Fluctuations" moved the same way as this thread, in the same document, in 4 of its 8 moves.

433332★123456
  1. ★This thread
  2. 1Higher Procurement Costs and Foreign Exchange Losses Due to Exchange-Rate Fluctuations4×
  3. 2Deterioration in Market Conditions Due to the Chinese Economic Slowdown, Natural Disasters and Sluggish Consumption3×
  4. 3Procurement Cost Stabilization and Expense Control3×
  5. 4Sluggish growth in corporate demand and expansion in personal demand3×
  6. 5Raw Material Procurement Risks Driven by Crude Oil Prices and Economic Conditions in China and Southeast Asia3×
  7. 6Expansion of the Market for High-Performance Products for Personal Use2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Lihit Lab. yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of disruptions to production, logistics, and sales caused by COVID-19 and large-scale disasters | LIHIT LAB.,INC. (7975) | Komori